Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

\uD83D\uDC65 Participants

\uD83E\uDD45 Goals

\uD83D\uDDE3 Discussion topics

...

Item

Presenter

Notes

move bespokefit support to infrastructure team

  • Immediate - Acting as backup for user support

  • Immediate - Reviewing/direct-merging "obvious maintenance" (like dependency update) PRs without your/Simon's involvement

  • May 13 - Acting as primary for user support (but pinging you pretty frequently for hard questions)

  • May 27 - Reviewing/direct-merging "bugfix" PRs without your/Simon's involvement

  • June 27 - Reviewing/direct-merging "API extension" PRs without your/Simon's involvement

  • July 15 - Making releases without your/Simon's involvement

  • July 30 - Reviewing/direct-merging "API breaking and behavior changing" PRs without your/Simon's involvement

DC, JH, and JW approve this timeline

bespokefit paper results

  • JH – Finished calculations for the paper (reviews paper draft).

  • PB – Did you use the ligand fragment set? I found some missing bond and angle parameters.

    • Related issue (but not using ligand fragment set mols)

      Github link macro
      linkhttps://github.com/openforcefield/openff-toolkit/issues/1256

user testing

  • DC – BSwope conversation is running a bit thin - We’ve opened up to other users and are starting to get chatter on the issue tracker.

  • (General) – JH will have a meeting with Xavier Lucas, JW will ensure a member of the infrastructure team is there to learn.

    • DM – Invite others who may benefit from this?

    • JW – I’d push back on that, in case XL needs to share screen, it may be unwanted to have more sets of eyes.

  • DC – In June, there’s a CCP BioSim conference in the UK. I suggested that JH gives a talk on BespokeFit there. I assume that’s OK.

  • JH – Yup, should I circulate the talk for review/approval beforehand?

  • JW + DM – No need to seek approval, but it’s nice to circulate for feedback.

  • DM – I’d love to have a copy of the talk for review and archival/future material.

  • DC – And we’re coming up on the next stage for the paper publication process. So expect to hear about that in a ~week.

✅ Action items

  •  

⤴ Decisions

...